Chemerin: A biomarker for cardiovascular disease in diabetic chronic kidney disease patients
Cardiovascular disease is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). The carotid intima-media thickness (CIMT) and arterial stiffness are useful markers of subclinical atherosclerosis and significantly correlate with various metabolic risk factors. Ch...
Main Authors: | Farag E Salama, Qasem A Anass, Abdelnaem A Abdelrahman, Elsayed B Saeed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2016;volume=27;issue=5;spage=977;epage=984;aulast=Salama |
Similar Items
-
Serum chemerin level in chronic kidney disease
by: Samiha Abo Eiyazeed Abd Rabo, et al.
Published: (2016-01-01) -
Chemerin level and the relation to insulin resistance in chronic kidney disease
by: Sahier Omar El-Khashab, et al.
Published: (2019-01-01) -
Cardiovascular biomarkers in chronic kidney disease
by: Đerić Mirjana, et al.
Published: (2010-01-01) -
Microparticles as biomarkers of early changes leading to cardiovascular disease in chronic kidney disease
by: Abbasian, Nima
Published: (2015) -
The role of chemerin in human disease
by: Magdalena Stojek
Published: (2017-02-01)